A Medical Device Daily
MicroFluidic Systems (MFSI; Pleasanton, California) has signed a cooperative research and development agreement (CRADA) with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID; Fort Detrick, Maryland) to evaluate the company’s pathogen sample processing technologies and products.
MFSI said it has been awarded several prime contracts from the U.S. government, including one from the Department of Homeland Security’s (DHS) Homeland Security Advanced Research Projects Agency (HSARPA) to develop a Bioagent Autonomous Networked Detector (BAND) system.
One of the components of this automated pathogen detection system is MFSI’s cell lysis technology, which has been developed into a stand-alone commercial laboratory instrument called the BioLyser.
USAMRIID is one of several entities working with MFSI to provide initial user feedback on the product, the company said.
MFSI was founded in 2001 and is focused on the development of automated microfluidic systems for biological assays.
SourceOne Healthcare Technologies (Mentor, Ohio) and Shimadzu Medical Systems (Torrance, California), have signed a contract giving SourceOne rights to market and distribute a mobile X-ray system specifically manufactured by Shimadzu for SourceOne in the U.S.SourceOne is a distributor of medical-imaging systems, equipment, radiographic consumable supplies, and services to healthcare facilities in the U.S.
Shimadzu Medical Systems makes a range of diagnostic systems that are used in all areas of clinical applications, including CT, digital subtraction angiography, cardiovascular systems, digital radiography and fluoroscopy systems, ultrasound and general radiography.
Shimadzu will manufacture the mobile X-ray unit for SourceOne, which will distribute the system nationally as the Mobile Star II.
The Mobile Star II is a cordless mobile X-ray system designed to perform radiography examinations in re-mote locations away from a traditional radiography department.